How Does Parkinson’s Prevalence Differ by Gender, What Percentage of Men Are Affected Compared With Women, and What Biological Factors Explain the Difference? 👨👩🧠

This article is written by mr.hotsia, a long term traveler and storyteller who runs a YouTube travel channel followed by over a million followers. Over the years he has crossed borders and backroads throughout Thailand, Laos, Vietnam, Cambodia, Myanmar, India and many other Asian countries, sleeping in small guesthouses, village homes and roadside inns. Along the way he has listened to real life health stories from locals, watched how people actually live day to day, and collected simple lifestyle ideas that may help support better wellbeing in practical, realistic ways.

When families ask whether Parkinson’s disease affects men and women equally, the short truth is no, not exactly. Men are generally affected more often than women, but the size of that gap depends on which study you read, which region is being studied, and how researchers define the population. Some newer global reviews suggest the gap is smaller than older textbooks implied, while other narrative reviews and burden studies still describe a clear male predominance. So the cleanest answer is this: men usually have higher Parkinson’s prevalence than women, but the difference is not perfectly fixed across all countries and age groups.

A useful modern shorthand is that Parkinson’s prevalence is often described as about 1.4 to 1.5 times higher in men than in women. One 2024 epidemiology update summarized the Global Burden of Disease picture as a male-to-female prevalence ratio of about 1.4:1, while a 2024 narrative review stated that prevalence is about 1.5 times higher in men. At the same time, a 2024 systematic review and meta-analysis found that prevalence in men and women was similar overall in the pooled data, reminding us that regional and methodological differences can shrink or widen the apparent gap.

What percentage of men are affected compared with women?

This question sounds simple, but the numbers depend heavily on the age band being measured. Parkinson’s rises sharply with age, so percentages in adults over 60 will be much higher than in all adults combined. That means there is no single one-size-fits-all lifetime percentage for all men and all women.

What the evidence supports more clearly is the ratio between men and women. If women in a given older population had a prevalence of about 1.0%, a male-to-female ratio of 1.4:1 would suggest men in that same population might be around 1.4%. If the ratio were 1.5:1, men would be around 1.5% compared with 1.0% in women. This is a comparison tool, not a universal global fixed percentage. The safest modern summary is that men are commonly reported as having about 40% to 50% higher prevalence than women, although some datasets, especially some Asian analyses, show a smaller difference.

There is also evidence that the sex gap varies by geography. The 2022 meta-analysis on gender differences reported that the lowest male-to-female prevalence ratio appeared in Asia, and suggested the ratio may even be trending toward greater sex equality over time. Meanwhile, broader reviews still note stronger male predominance in many Western populations. So the map is not painted with one brushstroke. It is more like a mosaic, with some tiles showing a wider gap and others a narrower one.

Why do men usually show higher Parkinson’s prevalence?

The current scientific answer is not one single cause. It is probably a braid of hormonal, genetic, immune, environmental, and possibly diagnostic factors.

1. Estrogen may offer some neuroprotective effects

One of the most common biological explanations is that estrogen may help protect dopaminergic neurons, the very cells that are heavily affected in Parkinson’s disease. Recent reviews describe estrogen as potentially reducing oxidative stress, inflammation, and dopaminergic neuron loss. That does not mean estrogen makes women immune. It simply means female hormonal biology may provide some buffering effect, especially earlier in life. This is one of the most discussed explanations for why men often show higher Parkinson’s risk and prevalence.

2. Men and women may differ in dopamine system biology

Reviews also describe sex-related differences in dopamine transporter biology, gene regulation, and brain resilience. Some authors note that females may have greater baseline dopamine transporter availability or different dopamine-related regulation that could help the nigrostriatal system resist injury differently. These are not simple all-or-nothing differences, but they may help explain why the same environmental or aging stress might not land identically in male and female brains.

3. Immune and inflammatory responses may differ by sex

Another major explanation involves neuroinflammation. Parkinson’s is increasingly understood as a disease shaped not only by dopamine loss but also by immune and inflammatory processes. Recent reviews on sex differences emphasize that male and female immune responses differ across the lifespan, and these differences may affect vulnerability to neurodegeneration. In plain language, the brain’s internal fire response system may not behave the same way in men and women. That could influence who develops disease more easily and how the disease behaves after it starts.

4. Genetic and epigenetic regulation may not be identical

Researchers also point to sex-based differences in gene expression and epigenetic regulation. This area is still developing, but reviews suggest that sex chromosomes, hormone-sensitive gene pathways, and sex-specific regulation of stress and inflammation may help shape Parkinson’s risk differently in men and women. This does not mean there is one “male Parkinson’s gene” and one “female Parkinson’s gene.” It means the same biological orchestra may be playing from slightly different sheet music.

5. Environmental and occupational exposures may contribute

Biology is not the whole story. Men in many populations have historically had greater exposure to pesticides, solvents, metals, and other occupational or environmental risk factors linked with Parkinson’s disease. Some reviews still consider this an important part of the sex difference. In other words, the male predominance may reflect not only what happens inside the body, but also what kinds of work and exposures have been more common outside it.

Is the gender gap always large?

No. This is where the story becomes more interesting.

The 2024 systematic review and meta-analysis found similar prevalence in men and women overall, which contrasts with the older and still common view of clear male predominance. The 2022 meta-analysis likewise suggested the male/female prevalence ratio may be lower than previously reported and may be decreasing over time. That does not erase the many studies showing male predominance, but it does mean researchers are becoming more cautious. Some of the older difference may have reflected study design, detection patterns, access to care, or under-recognition in women.

So today, the most honest position is this: male predominance is still a common finding, but the exact size of the difference is not settled into stone. A fair working summary is that men are usually more affected, often by about 1.4 to 1.5 times, while some newer pooled analyses show smaller differences and even near-similarity depending on region and methods.

Does gender change how Parkinson’s looks clinically?

Yes, it can. Reviews note that sex differences in Parkinson’s are not limited to prevalence alone. Women and men can differ in symptom patterns, progression features, and treatment complications. For example, some more recent literature points out that although men may develop Parkinson’s more often, women may show different clinical features and may have different risks for treatment-related complications such as levodopa-induced dyskinesia. That means sex matters not only for who gets Parkinson’s, but also for how the journey unfolds.

The bottom line

Parkinson’s disease is generally more common in men than in women, but the size of the gap depends on the source. A practical evidence-based summary is that men often show about 1.4 to 1.5 times the prevalence seen in women, meaning roughly 40% to 50% higher prevalence in many datasets. Still, some newer pooled analyses suggest the sex difference may be smaller than older assumptions, especially in some regions such as Asia.

The biological reasons are likely mixed. The leading explanations include possible estrogen-related neuroprotection, differences in dopamine system biology, immune and inflammatory responses, genetic and epigenetic regulation, and environmental exposure patterns that may differ between men and women. No single explanation fully solves the puzzle, but together they help explain why the disease often leans male without doing so equally everywhere.

FAQs: Parkinson’s and Gender Differences

1. Is Parkinson’s more common in men or women?

Most studies report that Parkinson’s is more common in men. A common estimate is that prevalence is about 1.4 to 1.5 times higher in men, though some newer meta-analyses suggest the gap may be smaller in some regions.

2. What does a 1.5 to 1 male-to-female ratio mean?

It means that for every 1 woman with Parkinson’s in a comparable group, there may be about 1.5 men. In practical terms, men would have roughly 50% higher prevalence in that comparison.

3. Are the percentages the same in every continent?

No. Some studies suggest the male/female gap is smaller in Asia than in many Western regions.

4. Why might women have lower Parkinson’s prevalence?

One major theory is that estrogen may have neuroprotective effects, possibly reducing oxidative stress, inflammation, and dopaminergic neuron loss.

5. Is estrogen the only explanation?

No. Researchers also point to immune differences, dopamine system biology, gene regulation, and environmental exposure differences.

6. Do some studies show men and women are affected equally?

Yes. A 2024 systematic review and meta-analysis reported similar prevalence in men and women overall, which shows the issue is more nuanced than older assumptions suggested.

7. Could underdiagnosis affect the gender gap?

Possibly. Differences in healthcare access, recognition, and study design may partly affect how large the male predominance appears in some datasets. This is one reason researchers are more cautious now about quoting one fixed number.

8. Do men and women experience Parkinson’s the same way once diagnosed?

Not always. Reviews suggest there can be sex-related differences in symptoms, progression, and treatment complications.

9. Does age affect the male-to-female difference?

Yes, it may. Some epidemiologic work suggests the male-to-female ratio can change with age and may rise in some older groups.

10. What is the simplest way to understand the gender difference in Parkinson’s?

Men usually seem to carry more of the disease burden, but the reason is likely not one giant cause. It is more like several small rivers joining the same current: hormones, immunity, genes, aging, and life exposures all flowing together.

I’m Mr.Hotsia, sharing 30 years of travel experiences with readers worldwide. This review is based on my personal journey and what I’ve learned along the way. Learn more